ABIO Arca Biopharma Inc

ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.

$3.46
As of 04/14/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/28/2009
Outstanding shares:  14,410,143
Average volume:  463,354
Market cap:   $50,435,501
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00211Y506
ISIN:        US00211Y5069
Sedol:      BJLNCR1
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.64
PS ratio:   0.00
Return on equity:   -20.93%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy